Waiving vaccine patents?

Date 21/05/2021

This article contemplates whether waiving vaccine patents can contribute positively to advancing the COVID-19 vaccination worldwide (SDG 3).

TopicInternational Economics

Príncipe de Vergara, 51
28006 Madrid, España
Telephone: +34 91 781 6770
Fax: +34 91 426 2157
Information: info[arroba]rielcano.org

Texts
María Santillán O’Shea

Alex Gould
Ivanosca López-Valerio (text editing)

Coordinated by
Aitor Pérez
Iliana Olivié
Ivanosca López-Valerio

Development
Julia Menéndez

Other publications and events